Regulatory guidance recognizes that advanced therapy medicinal products differ fundamentally from conventional drugs because variability may arise from living systems, manufacturing environments, and ...
Read more
The IR Sant Pau has received funding from the national call to advance the development of Fanconinib, the first specific inhibitor designed to block the FA/BRCA DNA repair pathway.
Read more
Identifican un nuevo mecanismo molecular que contribuye al desarrollo y progresión del cáncer de pulmón. El estudio se centra en el gen RBM10, alterado en una parte de los pacientes con este tumor,...
Read more
Having alternatives with fewer drugs may reduce cumulative lifetime exposure to medication and offers new options in cases of resistance or intolerance to integrase inhibitors
Read more
Sant Joan de Déu coordinates the European project AriChall, an international initiative that promotes a new clinical trial with the aim of identifying a treatment for children with acute lymphoblasti...
Read more
Tecnyfluor is a high-performance material belonging to the family of fluorinated elastomers, specially designed for industrial applications requiring superior chemical, thermal, and mechanical resista...
Read more
Nuevos hallazgos demuestran la implicación de la MMP25 en la respuesta inflamatoria asociada al desarrollo del daño vascular
Read more
La espirometría es una prueba sencilla, no invasiva y de bajo coste, utilizada de forma habitual para evaluar la función pulmonar. Según el estudio, este indicador puede ofrecer una señal temprana...
Read more
A pesar de experimentar las primeras dificultades o síntomas evidentes, las personas diagnosticadas, al principio, pueden llevar a cabo sin ayuda la mayoría de sus actividades de la vida diaria. Sin...
Read more
ABE Capital and Columbus Venture Partners have reached an agreement to acquire a majority stake in Sermes CRO, a Spanish contract research organization specializing in end-to-end management of clinica...
Read more
Un grupo del Cima participa en una investigación que abre la puerta a desarrollar nuevos tratamientos para los pacientes que no responden a las terapias
Read more
The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
